Standout Papers

Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma 2021 2026 2022 2024137
  1. Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma (2021)
    Fanhua Kong, Qifa Ye et al. Theranostics

Immediate Impact

1 by Nobel laureates 5 from Science/Nature 53 standout
Sub-graph 1 of 25

Citing Papers

Hepatocellular carcinoma: signaling pathways and therapeutic advances
2025 Standout
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
2025 Standout
2 intermediate papers

Works of Xi Liu being referenced

Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma
2021 Standout
Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer
2016
and 2 more

Author Peers

Author Last Decade Papers Cites
Xi Liu 848 1141 266 64 1.7k
Yanyang Tu 739 1195 280 66 1.7k
Jing Zhang 917 1318 356 76 1.9k
Giuseppina De Petro 995 1093 237 65 1.8k
Jun Deng 725 968 217 73 1.3k
Shujuan Shao 675 1220 308 61 1.7k
Xian Lin 622 1194 466 62 1.7k
Huiling Yang 538 1279 464 65 1.7k
Yue Ming 487 1014 243 77 1.5k
Pai‐Sheng Chen 758 1324 242 37 1.8k
Yue Fan 670 1162 300 60 1.6k

All Works

Loading papers...

Rankless by CCL
2026